Histone Methyltransferases Plays a Fundamental role on Nicotine Preference in Zebrafish

JOAQUIN ORTIZ, LEANDRO ROCCO, MARIA PAULA FAILLACE, RAMON BERNABEU

San Luis, Argentina

Congreso; XXXVIII Reunión Anual de la SAN, Sociedad Argentina de Investigación en Neurociencias; 2023

Sociedad Argentina de Investigación en Neurociencias

Histone Methyltransferases Plays a Fundamental role on Nicotine Preference in ZebrafishJoaquin Ortiz1,2, Leandro Rocco1,2, Maria Paula Faillace1*,and Ramon Bernabeu1*1University of Buenos Aires, Department of Physiology and Institute of Physiology and Biophysics (IFIBIO-Houssay, UBA-CONICET), School of Medicine, Buenos Aires, Argentina.2These authors contributed equally to this work. * These authors share correspondence authorshipAbstractPsychostimulants regulate behavioral responses in zebrafish via epigenetic mechanisms. We have previously shown that DNA methylation and histone acetylation inhibition abolish nicotine-induced conditioned place preference (CPP) but little is known about the role of histone methylation in addictive-like behaviors. To assess the influence of histone methylation on nicotine-CPP, zebrafish were treated with a histone 3 (H3) lysine-9 (K9) dimethyltransferase G9a/GLP inhibitor, BIX-01294 (BIX), which was administered before conditioning sessions. We observed a dual effect of the inhibitor BIX: at high doses inhibited while at low doses potentiated nicotine reward. Transcriptional expression of α6 and α7subunits of the nicotinic acetylcholine receptor and of G9a, DNA methyl transferase-3, and HDAC-1 were upregulated in zebrafish with positive scores for nicotine-CPP. BIX treatment per sé did not affect transcriptional levels of epigenetic enzymes that regulate trimethylation or demethylation of H3. BIX reduced H3K9me2 protein levels in a dose-dependent manner in key structures of the reward pathway. Our data demonstrate that H3 methylation catalyzed by G9a/GLP is involved in nicotine-CPP induction. Dimethylation of K9 at H3 is an important epigenetic modification that should be considered as a potential therapeutic target to treat nicotine reward and perhaps other drug addictions.